Ann: MedAdvisor to launch in Asia with Zuellig Pharma, page-8

We’re a quiet bunch here gobs. Be gentle.

They haven’t found a cure for AIDS or a landlocked pile of lithium in Africa.

But what they do have is some nice building blocks to expose the platform to numbers far exceeding their current customer base. There’s a lot to like with high margins and growing ARPU.

There’s no Buffet quotes, animated gifs, rocket ships or last train (toot toot) posts here. So would much prefer a manageable rise over the next few months back to its previous highs ..... because I haven’t finished buying.